Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
161.67
+4.46 (2.84%)
At close: Aug 17, 2026, 4:00 PM EDT
160.50
-1.17 (-0.72%)
After-hours: Aug 17, 2026, 7:40 PM EDT
Guardant Health Stock Forecast
Stock Price Forecast
According to 25 analysts polled by S&P Global, Guardant Health stock has a consensus rating of "Strong Buy" and an average price target of $194.29. The average 1-year stock price forecast is 20.18% higher than the current stock price, while the lowest is $105 (-35.05%) and the highest is $225 (+39.17%).
Price Target: $194.29 (+20.18%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Guardant Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 16 | 16 | 16 | 19 | 19 | 19 |
| Buy | 5 | 4 | 4 | 5 | 5 | 5 |
| Hold | 2 | 2 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 23 | 22 | 22 | 25 | 25 | 25 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Maintains $195 | Buy | Maintains | $195 | +20.62% | Aug 5, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $200 | Buy | Maintains | $200 | +23.71% | Aug 4, 2026 |
| Stephens | Stephens | Buy Maintains $195 | Buy | Maintains | $195 | +20.62% | Aug 4, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $135 → $193 | Buy | Reiterates | $135 → $193 | +19.38% | Aug 4, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $175 → $185 | Buy | Reiterates | $175 → $185 | +14.43% | Aug 4, 2026 |
Financial Forecast
Revenue This Year
1.35B
from 982.02M
Increased by 37.95%
Revenue Next Year
1.83B
from 1.35B
Increased by 34.99%
EPS This Year
-1.45
from -1.82
EPS Next Year
-0.45
from -1.45
EPS and Forward PE are based on non-GAAP adjusted numbers.